Navigation Links
API and MYBiomass Announce Joint-Development Agreement for the Production of Nanocellulose for Downstream Applications
Date:1/10/2017

API and MYBiomass announced a Joint-Development Work (JDA) for production of nanocellulose and cellulosic sugars from oil palm empty fruit-bunches (EFBs) into material as enhancing additives in textile, paper, and automotive parts amongst others. The JDA is funded by MYBiomass and harnesses MYBiomass’ strength in oil palm biomass supply, technology adaptation, market development, and combines this with API’s technical and material development expertise. MYBiomass’s goal is to be a pioneer in setting up commercial biorefineries with potential participation from technology providers, off-takers and investors. This is in-line with the Malaysian Biomass Initiative (MBI) as it addresses the potential of moving up the value-chain, promotes sustainable feedstock supply, and shifts focus to higher-value downstream production.

According to MYBiomass’s CEO Ms. R. Puvaneswari, “The biomass potential is huge but remains largely untapped. As an innovative business venture, MYBiomass uses an inclusive 360° public-private business model - bringing feedstock, technology, and market players to bridge supply-chain gaps, and manage risks involved; thus developing a sustainable ecosystem for Biorefineries. We are glad to partner with an innovative and capable company like API to support the national vision of being a regional green chemicals and materials hub. MYBiomass will work closely with downstream partners for product applications and move towards the establishment of the commercial Biorefinery."

API’s CEO Dr. Theodora Retsina remarks, “We are excited to work with MYBiomass to develop market and prototype applications using nanocellulose made from EFBs, which can add value to many established supply chains, including those targeted in this JDA. MYBiomass brings to this partnership innovative thinking to elevate the value created from Malaysia’s natural resources and the integration with partners along the entire supply chain to consumer products. API has developed a suite of nanocellulose products including hydrophilic and hydrophobic varieties. Our Bioplus™ production process is robust, flexible, low cost and can virtually use any biomass as feedstock."

According to Dr. Kim Nelson, VP Nanocellulose Technology, “We are very excited to expand our biorefinery technologies to Malaysia in support of the country’s vision to become a regional green chemicals and biomaterials hub. Upgrading residual biomass to next-generation, high-performance renewable materials such as nanocellulose in support of global job creation and sustainable economic growth is central to API’s mission.”    

About MYBiomass Sdn. Bhd.
MYBiomass is a special-purpose-vehicle of the MBI endorsed by the Malaysian Prime Minister during the Inaugural Meeting of the Global Science and Innovation Advisory Council (GSIAC) on 17 May 2011, in New York, United States. Initiated by the Malaysian Industry-Government Group for High Technology (MIGHT), MYBiomass is a joint-venture company, together with Felda Global Ventures and Sime Darby, to pioneer high-value green chemicals biorefinery through coordinated aggregation.
Additional information is online at http://www.mybiomass.com.my.

About American Process
Headquartered in Atlanta, Georgia, API and its affiliates focus on pioneering renewable materials, fuels, and chemicals from biomass and develop proprietary technologies to be scaled industrially throughout the world. API has been an active biorefinery innovator for over two decades and has developed and demonstrated multiple patented technologies in the field. API has over 100 years of collective experience in scale-up, project management, operations, engineering-procurement-construction, energy integration, and research and development.
Additional information is online at http://www.americanprocess.com.

For more information about MYBiomass Sdn. Bhd., and the Joint-Development Program, please contact:

Mr Winson Chong or Ms Sivasankari Ranganathan
Winson(at)mybiomass(dot)com(dot)my or sankari(at)mybiomass(dot)com(dot)my

Read the full story at http://www.prweb.com/releases/2017/01/prweb13971545.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. ForSight VISION4, Inc. Announces Acquisition by Roche
2. SiteOne Therapeutics Announces Research and Development Agreement With Amgen to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain
3. BioAtla and F1 Oncology Announce Global Collaboration to Develop Adoptive Cellular Therapies for Solid Tumors
4. Mirati Therapeutics Announces Proposed Public Offering of Common Stock
5. Resverlogix Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
6. Zenith Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
7. Avidity Biosciences Announces Publication on Targeting Therapeutic Oligonucleotides by Arthur A. Levin in the New England Journal of Medicine
8. Rexgenero Announces Formation of Scientific Advisory Board
9. Bioquark Inc. Announces Approval of Bioquantine Bio-Active Food Additives in Eurasian Customs Union
10. Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business
11. Exoskeleton Technology News Announces Launch of New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... different cell type. Many treatments for specific cancers, such as breast, prostate, or ... treatment is androgen deprivation therapy for advanced prostate cancer. , This therapy ...
(Date:8/16/2017)... edition of the Inc. 5000 features a now-familiar name: BioPoint ( http://biopointinc.com/ ... list for the third year in a row. Now in its 36th ... a set of quantitative metrics. In addition, BioPoint was also named to ... Bay State . ... ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical Diagnostics ... biotherapeutics development, announces the launch of the new NHS Agile biosensor chip ... binding data for a wide range of molecules, including small and large molecules, ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and ... programming through a series of upcoming panels and events. The partnership culminates with the ... Roosevelt Hotel in New York City. , “With our experience in producing the Immuno-Oncology ...
Breaking Biology Technology:
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
Breaking Biology News(10 mins):